vs
Side-by-side financial comparison of CACI INTERNATIONAL INC (CACI) and Organon & Co. (OGN). Click either name above to swap in a different company.
CACI INTERNATIONAL INC is the larger business by last-quarter revenue ($2.4B vs $1.5B, roughly 1.6× Organon & Co.). CACI INTERNATIONAL INC runs the higher net margin — 5.5% vs -13.6%, a 19.1% gap on every dollar of revenue. On growth, CACI INTERNATIONAL INC posted the faster year-over-year revenue change (8.5% vs -5.3%). CACI INTERNATIONAL INC produced more free cash flow last quarter ($221.4M vs $96.0M). Over the past eight quarters, CACI INTERNATIONAL INC's revenue compounded faster (7.4% CAGR vs -3.6%).
CACI International Inc is a U.S.-headquartered multinational professional services and information technology firm. It delivers custom technology solutions, cybersecurity services, data analytics, and mission-critical operational support to government defense, intelligence, civilian agencies, and select private sector clients.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
CACI vs OGN — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.4B | $1.5B |
| Net Profit | $130.4M | $-205.0M |
| Gross Margin | — | 49.2% |
| Operating Margin | 9.7% | -9.8% |
| Net Margin | 5.5% | -13.6% |
| Revenue YoY | 8.5% | -5.3% |
| Net Profit YoY | 16.6% | -288.1% |
| EPS (diluted) | $5.88 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $2.4B | — | ||
| Q4 25 | $2.2B | $1.5B | ||
| Q3 25 | $2.3B | $1.6B | ||
| Q2 25 | $2.3B | $1.6B | ||
| Q1 25 | $2.2B | $1.5B | ||
| Q4 24 | $2.1B | $1.6B | ||
| Q3 24 | $2.1B | $1.6B | ||
| Q2 24 | $2.0B | $1.6B |
| Q1 26 | $130.4M | — | ||
| Q4 25 | $123.9M | $-205.0M | ||
| Q3 25 | $124.8M | $160.0M | ||
| Q2 25 | $157.9M | $145.0M | ||
| Q1 25 | $111.9M | $87.0M | ||
| Q4 24 | $109.9M | $109.0M | ||
| Q3 24 | $120.2M | $359.0M | ||
| Q2 24 | $134.7M | $195.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 49.2% | ||
| Q3 25 | — | 53.5% | ||
| Q2 25 | — | 54.8% | ||
| Q1 25 | — | 55.6% | ||
| Q4 24 | — | 56.3% | ||
| Q3 24 | — | 58.3% | ||
| Q2 24 | — | 58.4% |
| Q1 26 | 9.7% | — | ||
| Q4 25 | 9.3% | -9.8% | ||
| Q3 25 | 9.3% | 15.2% | ||
| Q2 25 | 9.0% | 14.4% | ||
| Q1 25 | 9.1% | 6.7% | ||
| Q4 24 | 8.6% | 8.1% | ||
| Q3 24 | 8.7% | 13.1% | ||
| Q2 24 | 9.7% | 14.6% |
| Q1 26 | 5.5% | — | ||
| Q4 25 | 5.6% | -13.6% | ||
| Q3 25 | 5.5% | 10.0% | ||
| Q2 25 | 6.9% | 9.1% | ||
| Q1 25 | 5.2% | 5.8% | ||
| Q4 24 | 5.2% | 6.8% | ||
| Q3 24 | 5.8% | 22.7% | ||
| Q2 24 | 6.6% | 12.1% |
| Q1 26 | $5.88 | — | ||
| Q4 25 | $5.59 | $-0.78 | ||
| Q3 25 | $5.63 | $0.61 | ||
| Q2 25 | $7.11 | $0.56 | ||
| Q1 25 | $5.00 | $0.33 | ||
| Q4 24 | $4.88 | $0.42 | ||
| Q3 24 | $5.33 | $1.38 | ||
| Q2 24 | $5.97 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.0M | $574.0M |
| Total DebtLower is stronger | $5.2B | $8.6B |
| Stockholders' EquityBook value | $4.3B | $752.0M |
| Total Assets | $11.6B | $12.9B |
| Debt / EquityLower = less leverage | 1.21× | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.0M | — | ||
| Q4 25 | $423.0M | $574.0M | ||
| Q3 25 | $133.0M | $672.0M | ||
| Q2 25 | $106.2M | $599.0M | ||
| Q1 25 | $223.9M | $547.0M | ||
| Q4 24 | $175.7M | $675.0M | ||
| Q3 24 | $440.7M | $763.0M | ||
| Q2 24 | $134.0M | $704.0M |
| Q1 26 | $5.2B | — | ||
| Q4 25 | $3.0B | $8.6B | ||
| Q3 25 | $2.8B | $8.8B | ||
| Q2 25 | $2.9B | $8.9B | ||
| Q1 25 | $3.1B | $9.0B | ||
| Q4 24 | $3.1B | $8.9B | ||
| Q3 24 | $1.8B | $8.7B | ||
| Q2 24 | $1.5B | $8.7B |
| Q1 26 | $4.3B | — | ||
| Q4 25 | $4.1B | $752.0M | ||
| Q3 25 | $4.0B | $906.0M | ||
| Q2 25 | $3.9B | $733.0M | ||
| Q1 25 | $3.7B | $542.0M | ||
| Q4 24 | $3.7B | $472.0M | ||
| Q3 24 | $3.7B | $493.0M | ||
| Q2 24 | $3.5B | $144.0M |
| Q1 26 | $11.6B | — | ||
| Q4 25 | $8.9B | $12.9B | ||
| Q3 25 | $8.7B | $13.6B | ||
| Q2 25 | $8.6B | $13.5B | ||
| Q1 25 | $8.6B | $13.2B | ||
| Q4 24 | $8.5B | $13.1B | ||
| Q3 24 | $7.2B | $12.8B | ||
| Q2 24 | $6.8B | $12.2B |
| Q1 26 | 1.21× | — | ||
| Q4 25 | 0.72× | 11.49× | ||
| Q3 25 | 0.69× | 9.74× | ||
| Q2 25 | 0.75× | 12.14× | ||
| Q1 25 | 0.84× | 16.52× | ||
| Q4 24 | 0.82× | 18.81× | ||
| Q3 24 | 0.50× | 17.75× | ||
| Q2 24 | 0.44× | 60.11× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $248.3M | $141.0M |
| Free Cash FlowOCF − Capex | $221.4M | $96.0M |
| FCF MarginFCF / Revenue | 9.4% | 6.4% |
| Capex IntensityCapex / Revenue | 2.5% | 3.0% |
| Cash ConversionOCF / Net Profit | 1.90× | — |
| TTM Free Cash FlowTrailing 4 quarters | $641.6M | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $248.3M | — | ||
| Q4 25 | $154.2M | $141.0M | ||
| Q3 25 | $171.1M | $264.0M | ||
| Q2 25 | $156.0M | $220.0M | ||
| Q1 25 | $230.3M | $75.0M | ||
| Q4 24 | $126.0M | $390.0M | ||
| Q3 24 | $34.7M | $141.0M | ||
| Q2 24 | $157.2M | $332.0M |
| Q1 26 | $221.4M | — | ||
| Q4 25 | $138.2M | $96.0M | ||
| Q3 25 | $154.1M | $218.0M | ||
| Q2 25 | $128.0M | $181.0M | ||
| Q1 25 | $214.1M | $43.0M | ||
| Q4 24 | $116.1M | $335.0M | ||
| Q3 24 | $23.2M | $99.0M | ||
| Q2 24 | $134.6M | $300.0M |
| Q1 26 | 9.4% | — | ||
| Q4 25 | 6.2% | 6.4% | ||
| Q3 25 | 6.7% | 13.6% | ||
| Q2 25 | 5.6% | 11.4% | ||
| Q1 25 | 9.9% | 2.8% | ||
| Q4 24 | 5.5% | 21.0% | ||
| Q3 24 | 1.1% | 6.3% | ||
| Q2 24 | 6.6% | 18.7% |
| Q1 26 | 2.5% | — | ||
| Q4 25 | 0.7% | 3.0% | ||
| Q3 25 | 0.7% | 2.9% | ||
| Q2 25 | 1.2% | 2.4% | ||
| Q1 25 | 0.7% | 2.1% | ||
| Q4 24 | 0.5% | 3.5% | ||
| Q3 24 | 0.6% | 2.7% | ||
| Q2 24 | 1.1% | 2.0% |
| Q1 26 | 1.90× | — | ||
| Q4 25 | 1.24× | — | ||
| Q3 25 | 1.37× | 1.65× | ||
| Q2 25 | 0.99× | 1.52× | ||
| Q1 25 | 2.06× | 0.86× | ||
| Q4 24 | 1.15× | 3.58× | ||
| Q3 24 | 0.29× | 0.39× | ||
| Q2 24 | 1.17× | 1.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
